Plasmids carrying cloned segments of thefrd operon of Escherichia coli have been used in genetic complementation studies to identify two independent mutants defective in the frdD gene, which encodes the hydrophobic FrdD polypeptide of the fumarate reductase complex. Mutations in the frdA and frdB genes have also been mapped by this technique. One of the FrdD peptide mutants, DW109 (frdD-109), showed that fumarate reductase was not as tightly bound to the membrane in this mutant. In addition, the mutation in the FrdD peptide caused an almost total loss of the ability of the enzyme to oxidize either menaquinol-6, a physiological donor for fumarate reduction, or reduced benzyl viologen. However, the mutation did not impair the ability of the membrane-bound fumarate reductase complex to function with succinate as substrate, as evidenced by unchanged turnover numbers for phenazine methosulfate and 2,3-dimethoxy-5-methyl-6-pentyl-1,4-benzoquinone (a quinone analogue) reductase activities. These data establish the essential role of the FrdD polypeptide both in the interaction of the enzyme with reduced menaquinone and thus in anaerobic respiration with fumarate as electron acceptor, and in binding the enzyme to the membrane.
Fumarate reductase ofEscherichia coli is a membrane-bound complex composed of four nonidentical polypeptides, which catalyzes the final step in anaerobic respiration when fumarate is the terminal electron acceptor (1) . The catalytic domain is composed ofthe FrdA subunit (66 kDa), which contains the active site and a covalently bound FAD prosthetic group (2) , and the FrdB subunit (27 kDa) , which is an iron-sulfur protein predicted from sequence studies to contain all three of the clusters (a 2Fe-2S, 4Fe-4S, and 3Fe-xS) recently identified in the enzyme (3) (4) (5) . Two hydrophobic polypeptides, FrdC and FrdD, of 15 kDa and 13 kDa, respectively, serve to anchor the catalytic subunits to the cytoplasmic membrane (6, 7) . They also have essential roles in the interactions of fumarate reductase with quinones (8, 9) . Fumarate reductase readily functions as a succinate dehydrogenase, for which it is known to substitute in sdh mutants of E. coli if amplified by plasmid vectors (10) , in accord with the marked similarities in the physical and catalytic properties ofthese enzymes (11) (12) (13) (14) . In the reduction of quinones by the enzyme, FrdC and FrdD thus assume roles analogous to those of peptides C11-3 and CII-of mammalian complex II (succinate-ubiquinone oxidoreductase), which confer ubiquinone reductase activity on the succinate dehydrogenase (14) . The combined presence of FrdC and FrdD is essential, since neither peptide alone was found capable of binding fumarate reductase to E. coli membranes or permitting quinone reduction (9) . Whether or not FrdC and FrdD each contain a quinone-binding site and if such sites are formed only on association of the subunits is not known. Two protein-bound ubisemiquinone species are thought to be generated, however, during ubiquinone reduction by the functionally equivalent complex II of beef heart (15) . It is of interest, therefore, that the fumarate reductase complex was rendered incapable of catalyzing the oxidation of 2,3-dimethyl-1,4-naphthoquinol (DMNH2) by a single amino acid change in the FrdC peptide (16) .
Early genetic studies located thefrd locus at 94 min on the E. coli genetic map (17) (18) (19) . The genes encoding the four fumarate reductase polypeptides have since been cloned and their DNA sequences were determined (3, 20, 21) . Recently, it has been shown that the four genes (frdA, -B, -C, and -D) comprise an operon that is regulated at the transcriptional level (22) . To date, only a single mutation (frdC) has been localized within the frd operon (16) . In this paper, we describe the isolation and identification by genetic complementation analyses of additional E. coli mutants defective in each of the other three peptides that comprise the fumarate reductase complex. Also described for one of the mutants is the effect of a mutation in thefrdD gene on the assembly and catalytic properties of the fumarate reductase complex. The defective FrdD polypeptide severely decreased the amount of complex associated with isolated membranes and caused almost total loss of the ability of the enzyme to oxidize menaquinol-6, a physiological electron donor for fumarate reduction, and reduced benzyl viologen. The mutation had little effect, however, on the slower succinate oxidation activity of the complex with phenazine methosulfate (PMS) and the ubiquinone analogue 2,3-dimethoxy-5-methyl-6-pentyl-1,4-benzoquinone (DPB) as electron acceptors. These data establish the essential role of the FrdD polypeptide both in the binding of the enzyme to the cytoplasmic membrane and in the interaction of the enzyme with reduced menaquinone, and therefore in energy transduction.
MATERIALS AND METHODS
Bacterial Strains and Plasmids. All E. coli strains used in these experiments are K-12 derivatives (Table 1) . The plasmids used in the frd mutant complementation experiments are Apr (ampicillin resistant) pBR322 derivatives (Table 1 ; Fig. 1 ). Plasmid pFRD1144 (frdA+ -B+ -C+) was the gift of J. H. Weiner (Univ. of Alberta, Edmonton, Canada). EndoAbbreviations: PMS, phenazine methosulfate; DPB, 2,3-dimethoxy-5-methyl-6-pentyl-1,4-benzoquinone; DMNH2, reduced 2,3-dimethyl-1,4-naphthoquinone; HOQNO, 2-n-heptyl-4-hydroxyquinoline N-oxide; MNNG, N-methyl-N'-nitro-N-nitrosoguanidine; Apr, ampicillin resistance. tPresent address: University of Wisconsin Medical School, Madi- son, WI 53706.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. nuclease digestions, ligation of DNA, analysis of restriction fragments, cell transformations, and DNA preparations were performed as described (23, 24) . For construction ofpFRD33 (frdC+ -D+), the small Hpa I fragment (688 base pairs) was deleted from pGC1002 (7, 8) and cells were then exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) (50 ,g/ml) for 30 min at 37°C in 0.1 M citrate buffer (pH 5.5) (25) . After MNNG treatment, the cells were washed once with 0.1 M potassium phosphate buffer (pH 7.0), resuspended in glycerol (40 mM) minimal medium, and grown aerobically overnight at 37°C. The culture was then subjected to two cycles of ampicillin treatment (25 ,ug/ml) under anaerobic culture conditions in glycerol fumarate medium, and mutants were selected as described (18). P1 Transduction. Procedures for P1 transduction were as described (26) . The recAS6 allele was transferred from RPG51 (recA srl::TnJO) to the recipient strain (Table 1) by P1 transduction and selection for tetracycline resistance on Luria tetracycline plates. To confirm that tetracycline-resistant recipients were recA, each strain was tested for increased sensitivity to UV killing relative to recA+ strains.
Measurement of Cell Growth Yield. Anaerobic growth was monitored as described (22) . Cell growth yields were determined by measuring the total amount of protein produced in cells grown to stationary phase. Protein content was measured by the method of Peterson (27) using bovine serum albumin as a standard. Growth yield is reported as percentage total cell protein in mutant strains relative to the DW3110 strain, which is wild type for fumarate reductase.
Enzyme Assays. Succinate PMS and succinate DPB oxidoreductase activities and fumarate-dependent oxidation of reduced benzyl viologen were determined as described (9) .
Oxidation of menaquinol-6 was monitored at 272 nm (Imm = 16.4) in 1-ml anaerobic cuvettes containing 20 mM potassium phosphate, 20 mM sodium borate buffer (pH 6.7) (38°C), and 30 mM octyl-3-D-glucopyranoside. Glucose oxidase, 20 mM glucose, and catalase were present to ensure complete anaerobiosis (9) before addition of reduced quinone and 1 mM fumarate to start the reaction. Menaquinone-6 was reduced and stored in ethanol according to published methods (28) . Histidyl-FAD and protein contents of enzyme preparations were determined as in previous work (9) . (Table 1) . These mutants were unable to grow on solid or liquid glycerol fumarate minimal media under O2-free culture conditions. It was subsequently confirmed that each strain was defective in the frd locus by testing whether plasmid pGC1002 restored the ability of the mutant to grow on this medium. Transformation of frd recA and frd recA' strains (Table 1) was performed with each of the individual frd' plasmids described in Table 1 and Fig. 1 to identify the location of the respectivefrd mutations. Complementation of the frd mutant strains was generally scored after 2-4 days, as evidenced by colony development on anaerobic glycerol fumarate minimal ampicillin medium at 370C. Because it is known whichfrd genes are present on each complementation test plasmid, the identity of the defective frd gene in each mutant strain could thus be determined.
Mutations in the frdA and frdB Genes. Using the frd' plasmid complementation test system described above, we have identified six mutants defective for frdA and three mutants defective forfrdB (Table 1) . Strains DW103, DW105, DW107, DW112, DW113, and DW121 gave frd+ transformants when plasmid pFRD105 or pGC1002 but not when pFRD39 or pFRD33 was used as the test plasmid. These results indicate that these strains contain a defective frdA gene. Strains DW101, DW102, and DW123 were complemented by pFRD39 and pGC1002 but not with the other plasmids tested and thus are frdB mutants.
Mutations in the frdD Gene. Strains NW106 and NW109 gave a frd+ phenotype when transformed with either plasmid pFRD33 or pFRD38 and subsequently grown on glycerol fumarate minimal medium anaerobically. Nofrd+ transformants were obtained, however, when these strains were transformed with plasmids lacking a wild-type copy of the frdD+ gene (i.e., pFRD105, pFRD39, pFRD23, pFRD1144, or pBR322). Strains DW106 and DW109 gave identical frd+ transformation results to those seen for the NW106 and NW109 mutants. These results conclusively demonstrate that the frd mutation in DW109 is located in the frdD gene.
Revertants of NW106 and NW109 were selected by plating cultures on glycerol fumarate minimal plates followed by incubation under anaerobic conditions as described for the initial frd mutant isolation procedure. An E. coli uncH mutant strain, RH139 (uncH239), which is known to contain a point mutation, was used as a control (29) . The frequency of reversion of both NW106 and of NW109 was found to be similar to that of RH139 (1 x 10-9) and suggests that the mutations in the two frdD mutants are also point mutations (data not shown).
One of the frdD mutants (DW109) was further characterized. No growth of the mutant occurred in the absence of the frdD+ plasmid (Table 2 ). However, the mutant was able to grow at a rate similar to wild-type cells (frdD+) when it was (9) . Enzyme associated with cytoplasmic fraction was found not to require preactivation, consistent with previous observations (9) .
The data presented in Table 3 establish that membranes isolated from the frdD mutant DW109 were not devoid of fumarate reductase, but rather contained -33% of the enzyme present in membranes isolated from wild-type or pFRD38 (frdD+) complemented cells, as determined by analysis for histidyl-FAD. The respective PMS and DPBreductase activities decreased accordingly. That the enzyme in membranes isolated from mutant cells was just as catalytically competent in these reactions as enzyme from normal membranes is indicated by the same high turnover number (15, 250 at 380C) in the PMS reductase assay and only slightly impaired efficiency in the reduction of DPB (Table 4 ). In contrast, the mutation in the FrdD peptide of strain DW109 caused a severe disproportionate (98%) loss in the ability of the membrane to oxidize reduced benzyl viologen with fumarate as the terminal electron acceptor. As a consequence, the turnover number for this reaction decreased from 50,000 to 2750 min-' (Table 4 tExpressed as percent of the frd' control (DW3110, pBR322) and determined as described in Materials and Methods. 
DISCUSSION
The precise locations of the individual genes within the frd operon are known from the DNA sequence analysis (3, 20, 21) . Knowledge of the endonuclease restriction sites within the operon has allowed us to construct a set of plasmids ( Fig.  1 ) that contain defined regions of the frd operon. The plasmids have been used in gene complementation studies to define the location of a number offrd mutations generated by MNNG mutagenesis. Transformation of the individual frd recA mutants with the appropriate frdA+, frdB+, frdC+, or frdD+ plasmids then confers the ability of the cells to grow on a glycerol fumarate medium under anaerobic culture conditions. Expression of thefrd genes present on these plasmids is from either thefrd promoter or from the trp promoter. This gene complementation assay has allowed the identification of E. coli mutants defective in the frdA, frdB, and frdD genes. All frd mutants tested in this study were complemented by plasmid pGC1002 (frdA+, -B+, -C+, -D+) under anaerobic growth conditions. The highest proportion of mutants obtained (six) were found to contain defects in the frdA gene, which codes for the 66-kDa FrdA flavoprotein polypeptide. Three mutants in thefrdB gene were also obtained (Table 1) ; this gene codes forthe 27-kDa FrdB polypeptide, which is the probable location of the three iron-sulfur clusters present in the fumarate reductase complex (4, 5, 7) . Analysis of the remaining frd mutants by the complementation assay procedure revealed that two strains DW106 (frdD106) and DW109 (frdDl09) were defective in the frdD gene, which also represents a class of mutants not previously described. One of these mutants (DW109) has been characterized in greater detail to determine the role of the FrdD polypeptide in the fumpirate reductase complex.
Evidence that the mutation in the FrdD polypeptide interferes with proper assembly of the fumarate reductase complex into the cytoplasmic membrane is provided by the lower membrane and higher cytoplasmic levels of enzyme seen in DW109 than in wild-type cells (Table 3) . That the experimentally observed distribution of enzyme might represent an equilibrium between free and loosely bound mutant complex established originally in the unbroken cells is considered unlikely. The membrane fraction of mutant cells, once isolated, maintained the same high turnover number in the PMS assay as normal membranes (Table 4 ) and showed no serious diminution of activity that would be expected to occur if more complex were lost to solution. Free complex has been shown previously to have a significantly lower turnover number (9000 min-') than membrane-bound complex (15,000 min-1 at 38°C) (9) . A question remaining is whether the lower level of defective fumarate reductase complex observed in DW109 membranes, which is only 33% of the complex of normal membranes (Table 3) , reflects a lower level of aberrant FrdD polypeptide or a weaker binding, and therefore greater loss, of mutant complex from the membrane at the time of cell breakage. Analysis by sodium dodecyl sulfate/polyacrylamide gel electrophoresis of fumarate reductase complex in wild-type and mutant membranes and of immunoprecipitates obtained from detergent extracts of whole cells with antibody directed to the whole complex showed no obvious differences in staining profiles (data not shown). These observations would suggest that the aberrant FrdD peptide is present in mutant cells at the same levels as intact FrdD peptide in normal cells. The elevated levels of soluble enzyme in the cytoplasmic fraction of DW109 cells are presumably the result, therefore, of disruption of a less tightly associated mutant complex.
The mutation in the FrdD peptide did not impair the ability of the membrane-bound fumarate reductase complex of DW109 to oxidize succinate, as indicated by the same high turnover numbers for PMS (-15,000 min-1) and DPB (-9000 min-') reduction as exhibited by wild-type membrane-bound (Table 4) . These data are in direct conflict with the conclusions of Weiner and co-workers that the FrdC and FrdD peptides are not involved in the oxidation of reduced benzyl viologen (16) . In fact, the magnitude of the change in turnover number noted for reduced benzyl viologen oxidation as a result of the mutation in the FrdD peptide closely resembles that incurred on solubilization of the enzyme (9) . Considered together, and in the absence of direct evidence for modulation of catalytic activity by the peptides, our data suggest that in normal membranes the major entry of electrons from reduced benzyl viologen into the fumarate reductase complex is at the level of the FrdC and FrdD peptides presumably from respiratory components of the membrane via menaquinol. The lower rate of reduced benzyl viologen oxidation observed when aberrant FrdD peptide is present would then reflect more restrictive sites of electron entry into the complex, such as those available on the soluble form of the enzyme. Weiner and co-workers consider the latter sites to be the main, not minor, reaction sites for benzyl viologen in the complex, based on their evidence that the defect in the FrdC peptide caused loss ofthe ability to oxidize reduced quinone (DMNH2) but not reduced benzyl viologen, and that the former reaction was inhibited by 2-n-heptyl-4-hydroxyquinoline N-oxide (HOQNO) but not the latter one (16) . The data reported in Tables 3-5 The data presented establish an essential role for the FrdD peptide in binding fumarate reductase to the cytoplasmic membrane and in oxidation of both reduced menaquinone and benzyl viologen. All three processes were severely impaired by the presence of aberrant FrdD peptide, which is believed to contain a single point mutation based on the reversion frequency of the mutant. The presence of aberrant FrdD peptide in the complex did not affect, however, the reduction of the ubiquinone analogue DPB, which might suggest that structural changes in the protein selectively prevented accommodation of reduced menaquinone. Alternatively, the mutation in the FrdD peptide, as that in the FrdC peptide, since the latter also prevented oxidation of reduced menaquinone (16) , may interfere with stabilization ofquinone radical species, which would be expected to be formed as protein-bound intermediates, possibly in a two-electron gating mechanism for one-and two-electron interchange between the enzyme and the quinone pool (30) .
